{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:01:09Z","timestamp":1784635269084,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12264-025-01565-3","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T01:11:37Z","timestamp":1767748297000},"page":"1441-1458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oligodendroglial Mutant Huntingtin Contributes to Neuroinflammation in Huntington\u2019s Disease Mice"],"prefix":"10.1007","volume":"42","author":[{"given":"Xinhui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1565_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH. Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 2014, 10: 204\u2013216.","journal-title":"Nat Rev Neurol"},{"key":"1565_CR2","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.3390\/ijms25073845","volume":"25","author":"H Tong","year":"2024","unstructured":"Tong H, Yang T, Xu S, Li X, Liu L, Zhou G, et al. Huntington\u2019s disease: Complex pathogenesis and therapeutic strategies. Int J Mol Sci 2024, 25: 3845.","journal-title":"Int J Mol Sci"},{"key":"1565_CR3","doi-asserted-by":"crossref","unstructured":"Deyell JS, Gulia R, La Spada AR. Selective vulnerability in Huntington's disease: From excitotoxicity, mitochondrial dysfunction, and transcription dysregulation to therapeutic opportunity. In: Huntington's Disease: Pathogenic Mechanisms and Implications for Therapeutics. 1st ed. Academic Press, 2024: 285\u2013309.","DOI":"10.1016\/B978-0-323-95672-7.00001-7"},{"key":"1565_CR4","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1111\/febs.12418","volume":"280","author":"CYD Lee","year":"2013","unstructured":"Lee CYD, Cantle JP, Yang XW. Genetic manipulations of mutant huntingtin in mice: New insights into Huntington\u2019s disease pathogenesis. FEBS J 2013, 280: 4382\u20134394.","journal-title":"FEBS J"},{"key":"1565_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113443","volume":"42","author":"Q Jia","year":"2023","unstructured":"Jia Q, Bai D, Zheng X, Zhu L, Ou K, Wang X, et al. Comparing HD knockin pigs and mice reveals the pathological role of IL-17. Cell Rep 2023, 42: 113443.","journal-title":"Cell Rep"},{"key":"1565_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41551-023-01007-3","volume":"7","author":"S Yan","year":"2023","unstructured":"Yan S, Zheng X, Lin Y, Li C, Liu Z, Li J, et al. Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington\u2019s disease. Nat Biomed Eng 2023, 7: 629\u2013646.","journal-title":"Nat Biomed Eng"},{"key":"1565_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/brain\/awac068","volume":"146","author":"L Abjean","year":"2023","unstructured":"Abjean L, Ben Haim L, Riquelme-Perez M, Gipchtein P, Derbois C, Palomares MA, et al. Reactive astrocytes promote proteostasis in Huntington\u2019s disease through the JAK2-STAT3 pathway. Brain 2023, 146: 149\u2013166.","journal-title":"Brain"},{"key":"1565_CR8","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","volume":"19","author":"M Faideau","year":"2010","unstructured":"Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: A correlation with Huntington\u2019s disease subjects. Hum Mol Genet 2010, 19: 3053\u20133067.","journal-title":"Hum Mol Genet"},{"key":"1565_CR9","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1021\/acschemneuro.8b00072","volume":"9","author":"C Lois","year":"2018","unstructured":"Lois C, Gonz\u00e1lez I, Izquierdo-Garc\u00eda D, Z\u00fcrcher NR, Wilkens P, Loggia ML, et al. Neuroinflammation in Huntington\u2019s disease: New insights with 11C-PBR28 PET\/MRI. ACS Chem Neurosci 2018, 9: 2563\u20132571.","journal-title":"ACS Chem Neurosci"},{"key":"1565_CR10","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","volume":"130","author":"YF Tai","year":"2007","unstructured":"Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, et al. Microglial activation in presymptomatic Huntington\u2019s disease gene carriers. Brain 2007, 130: 1759\u20131766.","journal-title":"Brain"},{"key":"1565_CR11","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/s41591-022-01919-8","volume":"28","author":"A Feigin","year":"2022","unstructured":"Feigin A, Evans EE, Fisher TL, Leonard JE, Smith ES, Reader A, et al. Pepinemab antibody blockade of SEMA4D in early Huntington\u2019s disease: A randomized, placebo-controlled, phase 2 trial. Nat Med 2022, 28: 2183\u20132193.","journal-title":"Nat Med"},{"key":"1565_CR12","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/mds.23236","volume":"25","author":"HSG Domino Investigators","year":"2010","unstructured":"HSG Domino Investigators. A futility study of minocycline in Huntington\u2019s disease. Mov Disord 2010, 25: 2219\u20132224.","journal-title":"Mov Disord"},{"key":"1565_CR13","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1212\/WNL.0000000000203217","volume":"100","author":"R Kumar","year":"2023","unstructured":"Kumar R, Claassen D, Mongan A, Hoehn B, Lin P, Cahir-Mcfarland E, et al. A phase 2 open-label study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous ANX005 in patients with, or at risk of, manifest Huntington\u2019s disease (HD) (S32009). Neurology 2023, 100: 3366.","journal-title":"Neurology"},{"key":"1565_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1474-4422(23)00454-4","volume":"23","author":"R Reilmann","year":"2024","unstructured":"Reilmann R, Anderson KE, Feigin A, Tabrizi SJ, Leavitt BR, Stout JC, et al. Safety and efficacy of laquinimod for Huntington\u2019s disease (LEGATO-HD): A multicentre, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Neurol 2024, 23: 243\u2013255.","journal-title":"Lancet Neurol"},{"key":"1565_CR15","doi-asserted-by":"publisher","first-page":"fcad084","DOI":"10.1093\/braincomms\/fcad084","volume":"5","author":"AA Roussakis","year":"2023","unstructured":"Roussakis AA, Gennaro M, Gordon MF, Reilmann R, Borowsky B, Rynkowski G, et al. A PET-CT study on neuroinflammation in Huntington\u2019s disease patients participating in a randomized trial with laquinimod. Brain Commun 2023, 5: fcad084.","journal-title":"Brain Commun"},{"key":"1565_CR16","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1002\/hbm.22391","volume":"35","author":"M Di Paola","year":"2014","unstructured":"Di Paola M, Phillips OR, Sanchez-Castaneda C, Di Pardo A, Maglione V, Caltagirone C, et al. MRI measures of corpus callosum iron and myelin in early Huntington\u2019s disease. Hum Brain Mapp 2014, 35: 3143\u20133151.","journal-title":"Hum Brain Mapp"},{"key":"1565_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1212\/01.WNL.0000138434.68093.67","volume":"63","author":"C Fennema-Notestine","year":"2004","unstructured":"Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 2004, 63: 989\u2013995.","journal-title":"Neurology"},{"key":"1565_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92641","volume":"2","author":"P McColgan","year":"2017","unstructured":"McColgan P, Seunarine KK, Gregory S, Razi A, Papoutsi M, Long JD, et al. Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington\u2019s disease. JCI Insight 2017, 2: e92641.","journal-title":"JCI Insight"},{"key":"1565_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.biopsych.2017.10.019","volume":"83","author":"P McColgan","year":"2018","unstructured":"McColgan P, Gregory S, Seunarine KK, Razi A, Papoutsi M, Johnson E, et al. Brain regions showing white matter loss in Huntington\u2019s disease are enriched for synaptic and metabolic genes. Biol Psychiatry 2018, 83: 456\u2013465.","journal-title":"Biol Psychiatry"},{"key":"1565_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00401-021-02362-8","volume":"142","author":"S Gabery","year":"2021","unstructured":"Gabery S, Kwa JE, Cheong RY, Baldo B, Ferrari Bardile C, Tan B, et al. Early white matter pathology in the fornix of the limbic system in Huntington disease. Acta Neuropathol 2021, 142: 791\u2013806.","journal-title":"Acta Neuropathol"},{"key":"1565_CR21","first-page":"2621","volume":"25","author":"RTY Teo","year":"2016","unstructured":"Teo RTY, Hong X, Yu-Taeger L, Huang Y, Tan LJ, Xie Y, et al. Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease. Hum Mol Genet 2016, 25: 2621\u20132632.","journal-title":"Hum Mol Genet"},{"key":"1565_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111291","volume":"40","author":"A Benraiss","year":"2022","unstructured":"Benraiss A, Mariani JN, Tate A, Madsen PM, Clark KM, Welle KA, et al. A TCF7L2-responsive suppression of both homeostatic and compensatory remyelination in Huntington disease mice. Cell Rep 2022, 40: 111291.","journal-title":"Cell Rep"},{"key":"1565_CR23","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.cell.2023.07.027","volume":"186","author":"O Hahn","year":"2023","unstructured":"Hahn O, Foltz AG, Atkins M, Kedir B, Moran-Losada P, Guldner IH, et al. Atlas of the aging mouse brain reveals white matter as vulnerable foci. Cell 2023, 186: 4117-4133.e22.","journal-title":"Cell"},{"key":"1565_CR24","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1038\/s41467-022-35388-x","volume":"13","author":"RG Lim","year":"2022","unstructured":"Lim RG, Al-Dalahmah O, Wu J, Gold MP, Reidling JC, Tang G, et al. Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation. Nat Commun 2022, 13: 7791.","journal-title":"Nat Commun"},{"key":"1565_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.nbd.2015.08.008","volume":"82","author":"Q Ma","year":"2015","unstructured":"Ma Q, Yang J, Li T, Milner TA, Hempstead BL. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington\u2019s disease. Neurobiol Dis 2015, 82: 466\u2013477.","journal-title":"Neurobiol Dis"},{"key":"1565_CR26","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1007\/s12035-023-03799-6","volume":"61","author":"CI Radulescu","year":"2024","unstructured":"Radulescu CI, Ferrari Bardile C, Garcia-Miralles M, Sidik H, Yusof NABM, Pouladi MA. Environmental deprivation effects on myelin ultrastructure in Huntington disease and wildtype mice. Mol Neurobiol 2024, 61: 4278\u20134288.","journal-title":"Mol Neurobiol"},{"key":"1565_CR27","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949783","volume":"21","author":"P Yin","year":"2020","unstructured":"Yin P, Liu Q, Pan Y, Yang W, Yang S, Wei W, et al. Phosphorylation of myelin regulatory factor by PRKG2 mediates demyelination in Huntington\u2019s disease. EMBO Rep 2020, 21: e49783.","journal-title":"EMBO Rep"},{"key":"1565_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bpa.12678","volume":"29","author":"A Hoffmann","year":"2019","unstructured":"Hoffmann A, Ettle B, Battis K, Reiprich S, Schlachetzki JCM, Masliah E, et al. Oligodendroglial \u03b1-synucleinopathy-driven neuroinflammation in multiple system atrophy. Brain Pathol 2019, 29: 380\u2013396.","journal-title":"Brain Pathol"},{"key":"1565_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115266","volume":"44","author":"Q Ma","year":"2025","unstructured":"Ma Q, Tian JL, Lou Y, Guo R, Ma XR, Wu JB, et al. Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson\u2019s disease via the prosaposin-GPR37-IL-6 axis. Cell Rep 2025, 44: 115266.","journal-title":"Cell Rep"},{"key":"1565_CR30","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/s41593-024-01730-3","volume":"27","author":"AO Sasmita","year":"2024","unstructured":"Sasmita AO, Depp C, Nazarenko T, Sun T, Siems SB, Ong EC, et al. Oligodendrocytes produce amyloid-\u03b2 and contribute to plaque formation alongside neurons in Alzheimer\u2019s disease model mice. Nat Neurosci 2024, 27: 1668\u20131674.","journal-title":"Nat Neurosci"},{"key":"1565_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s43587-025-00816-2","volume":"5","author":"S Schneeberger","year":"2025","unstructured":"Schneeberger S, Kim SJ, Geesdorf MN, Friebel E, Eede P, Jendrach M, et al. Interleukin-12 signaling drives Alzheimer\u2019s disease pathology through disrupting neuronal and oligodendrocyte homeostasis. Nat Aging 2025, 5: 622\u2013641.","journal-title":"Nat Aging"},{"key":"1565_CR32","doi-asserted-by":"publisher","first-page":"eabb8680","DOI":"10.1126\/sciadv.abb8680","volume":"6","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K, et al. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer\u2019s disease. Sci Adv 2020, 6: eabb8680.","journal-title":"Sci Adv"},{"key":"1565_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-023-00616-5","volume":"18","author":"JS Schlett","year":"2023","unstructured":"Schlett JS, Mettang M, Skaf A, Schweizer P, Errerd A, Mulugeta EA, et al. NF-\u03baB is a critical mediator of post-mitotic senescence in oligodendrocytes and subsequent white matter loss. Mol Neurodegener 2023, 18: 24.","journal-title":"Mol Neurodegener"},{"key":"1565_CR34","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","volume":"85","author":"B Huang","year":"2015","unstructured":"Huang B, Wei W, Wang G, Gaertig MA, Feng Y, Wang W, et al. Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes. Neuron 2015, 85: 1212\u20131226.","journal-title":"Neuron"},{"key":"1565_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol 2003, 465: 11\u201326.","journal-title":"J Comp Neurol"},{"key":"1565_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0076-6879(06)12008-X","volume":"412","author":"AP Osmand","year":"2006","unstructured":"Osmand AP, Berthelier V, Wetzel R. Imaging polyglutamine deposits in brain tissue. Methods Enzymol 2006, 412: 106\u2013122.","journal-title":"Methods Enzymol"},{"key":"1565_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/bioinformatics\/btn025","volume":"24","author":"R Li","year":"2008","unstructured":"Li R, Li Y, Kristiansen K, Wang JSOAP. Short oligonucleotide alignment program. Bioinformatics 2008, 24: 713\u2013714.","journal-title":"Bioinformatics"},{"key":"1565_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: A fast spliced aligner with low memory requirements. Nat Methods 2015, 12: 357\u2013360.","journal-title":"Nat Methods"},{"key":"1565_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nat Methods 2012, 9: 357\u2013359.","journal-title":"Nat Methods"},{"key":"1565_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011, 12: 323.","journal-title":"BMC Bioinformatics"},{"key":"1565_CR41","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014, 15: 550.","journal-title":"Genome Biol"},{"key":"1565_CR42","unstructured":"Storey JD, Bass AJ, Dabney A, Robinson D. qvalue: Q-value estimation for false discovery rate control. 2021. Available from: http:\/\/github.com\/jdstorey\/qvalue"},{"key":"1565_CR43","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41592-023-02014-7","volume":"20","author":"AS Castanza","year":"2023","unstructured":"Castanza AS, Recla JM, Eby D, Thorvaldsd\u00f3ttir H, Bult CJ, Mesirov JP. Extending support for mouse data in the molecular signatures database (MSigDB). Nat Methods 2023, 20: 1619\u20131620.","journal-title":"Nat Methods"},{"key":"1565_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al. SRplot: A free online platform for data visualization and graphing. PLoS One 2023, 18: e0294236.","journal-title":"PLoS One"},{"key":"1565_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 2001, 25: 402\u2013408.","journal-title":"Methods"},{"key":"1565_CR46","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J, Couselo FL, Bruno J, Carniglia L, Durand D, Lasaga M, et al. Neuroinflammation in Huntington\u2019s disease: A starring role for astrocyte and microglia. Curr Neuropharmacol 2022, 20: 1116\u20131143.","journal-title":"Curr Neuropharmacol"},{"key":"1565_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","volume":"12","author":"TH Palpagama","year":"2019","unstructured":"Palpagama TH, Waldvogel HJ, Faull RLM, Kwakowsky A. The role of microglia and astrocytes in Huntington\u2019s disease. Front Mol Neurosci 2019, 12: 258.","journal-title":"Front Mol Neurosci"},{"key":"1565_CR48","doi-asserted-by":"publisher","first-page":"11787","DOI":"10.3390\/ijms252111787","volume":"25","author":"X Li","year":"2024","unstructured":"Li X, Tong H, Xu S, Zhou G, Yang T, Yin S, et al. Neuroinflammatory proteins in Huntington\u2019s disease: Insights into mechanisms, diagnosis, and therapeutic implications. Int J Mol Sci 2024, 25: 11787.","journal-title":"Int J Mol Sci"},{"key":"1565_CR49","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4103\/NRR.NRR-D-24-00195","volume":"20","author":"A Kwakowsky","year":"2025","unstructured":"Kwakowsky A, Palpagama TH. Neuroinflammation as a therapeutic target in Huntington\u2019s disease. Neural Regen Res 2025, 20: 817\u2013818.","journal-title":"Neural Regen Res"},{"key":"1565_CR50","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ana.26753","volume":"94","author":"T Palpagama","year":"2023","unstructured":"Palpagama T, Mills AR, Ferguson MW, Vikas Ankeal P, Turner C, Tippett L, et al. Microglial and astrocytic responses in the human midcingulate cortex in Huntington\u2019s disease. Ann Neurol 2023, 94: 895\u2013910.","journal-title":"Ann Neurol"},{"key":"1565_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104963","volume":"143","author":"DK Wilton","year":"2020","unstructured":"Wilton DK, Stevens B. The contribution of glial cells to Huntington\u2019s disease pathogenesis. Neurobiol Dis 2020, 143: 104963.","journal-title":"Neurobiol Dis"},{"key":"1565_CR52","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1038\/s41591-023-02566-3","volume":"29","author":"DK Wilton","year":"2023","unstructured":"Wilton DK, Mastro K, Heller MD, Gergits FW, Willing CR, Fahey JB, et al. Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease. Nat Med 2023, 29: 2866\u20132884.","journal-title":"Nat Med"},{"key":"1565_CR53","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12264-022-00981-z","volume":"39","author":"X Hu","year":"2023","unstructured":"Hu X, Yu G, Liao X, Xiao L. Interactions between astrocytes and oligodendroglia in myelin development and related brain diseases. Neurosci Bull 2023, 39: 541\u2013552.","journal-title":"Neurosci Bull"},{"key":"1565_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12264-022-00992-w","volume":"39","author":"HR Peng","year":"2023","unstructured":"Peng HR, Zhang YK, Zhou JW. The structure and function of glial networks: Beyond the neuronal connections. Neurosci Bull 2023, 39: 531\u2013540.","journal-title":"Neurosci Bull"},{"key":"1565_CR55","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Tortosa E, MacDonald ME, Friend JC, Taylor SAM, Weiler LJ, Cupples LA, et al. Quantitative neuropathological changes in presymptomatic Huntington\u2019s disease. Ann Neurol, 49: 29\u201334.","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.3.CO;2-2"},{"key":"1565_CR56","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","volume":"50","author":"RH Myers","year":"1991","unstructured":"Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, et al. Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus. J Neuropathol Exp Neurol 1991, 50: 729\u2013742.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1565_CR57","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.molmed.2023.07.010","volume":"29","author":"C Ferrari Bardile","year":"2023","unstructured":"Ferrari Bardile C, Radulescu CI, Pouladi MA. Oligodendrocyte pathology in Huntington\u2019s disease: From mechanisms to therapeutics. Trends Mol Med 2023, 29: 802\u2013816.","journal-title":"Trends Mol Med"},{"key":"1565_CR58","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nmeth.1710","volume":"8","author":"A Kuhn","year":"2011","unstructured":"Kuhn A, Thu D, Waldvogel HJ, Faull RLM, Luthi-Carter R. Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain. Nat Methods 2011, 8: 945\u2013947.","journal-title":"Nat Methods"},{"key":"1565_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. TGF-\u03b2 signaling in health, disease, and therapeutics. Signal Transduct Target Ther 2024, 9: 61.","journal-title":"Signal Transduct Target Ther"},{"key":"1565_CR60","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12264-023-01111-z","volume":"40","author":"Y Lan","year":"2024","unstructured":"Lan Y, Han X, Huang F, Shi H, Wu H, Yang L, et al. Early growth response gene-1 deficiency interrupts TGF\u03b21 signaling activation and aggravates neurodegeneration in experimental autoimmune encephalomyelitis mice. Neurosci Bull 2024, 40: 283\u2013292.","journal-title":"Neurosci Bull"},{"key":"1565_CR61","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1582-4934.2010.01011.x","volume":"15","author":"G Battaglia","year":"2011","unstructured":"Battaglia G, Cannella M, Riozzi B, Orobello S, Maat-Schieman ML, Aronica E, et al. Early defect of transforming growth factor \u03b21 formation in Huntington\u2019s disease. J Cell Mol Med 2011, 15: 555\u2013571.","journal-title":"J Cell Mol Med"},{"key":"1565_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1756-6606-6-55","volume":"6","author":"A Di Pardo","year":"2013","unstructured":"Di Pardo A, Alberti S, Maglione V, Amico E, Cortes EP, Elifani F, et al. Changes of peripheral TGF-\u03b21 depend on monocytes-derived macrophages in Huntington disease. Mol Brain 2013, 6: 55.","journal-title":"Mol Brain"},{"key":"1565_CR63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1083\/jcb.200306038","volume":"163","author":"H Zhou","year":"2003","unstructured":"Zhou H, Cao F, Wang Z, Yu ZX, Nguyen HP, Evans J, et al. Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity. J Cell Biol 2003, 163: 109\u2013118.","journal-title":"J Cell Biol"},{"key":"1565_CR64","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1038\/s41467-020-16318-1","volume":"11","author":"H Yang","year":"2020","unstructured":"Yang H, Yang S, Jing L, Huang L, Chen L, Zhao X, et al. Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form. Nat Commun 2020, 11: 2582.","journal-title":"Nat Commun"},{"key":"1565_CR65","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41582-023-00877-0","volume":"19","author":"L Kiani","year":"2023","unstructured":"Kiani L. Insights into the toxic effects of mutant huntingtin. Nat Rev Neurol 2023, 19: 576.","journal-title":"Nat Rev Neurol"},{"key":"1565_CR66","doi-asserted-by":"publisher","first-page":"10855","DOI":"10.1074\/jbc.M804813200","volume":"284","author":"T Ratovitski","year":"2009","unstructured":"Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, D\u2019Ambola J, et al. Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J Biol Chem 2009, 284: 10855\u201310867.","journal-title":"J Biol Chem"},{"key":"1565_CR67","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","volume":"361","author":"G Bates","year":"2003","unstructured":"Bates G. Huntingtin aggregation and toxicity in Huntington\u2019s disease. Lancet 2003, 361: 1642\u20131644.","journal-title":"Lancet"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01565-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01565-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01565-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:02:24Z","timestamp":1784631744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01565-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01565-3","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}